Home › Funds › SMITH CHAS P & ASSOCIATES PA CPAS › MRK

SMITH CHAS P & ASSOCIATES PA CPAS position in MRK

MERCK & CO · Health Care

SMITH CHAS P & ASSOCIATES PA CPAS reported holding 352,837 shares of MRK (MERCK & CO) in its Q3 2026 13F filing — a position valued at US$51.5M, representing 2.53% of its reported portfolio and ranking #14 among its reported holdings. SMITH CHAS P & ASSOCIATES PA CPAS has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)352.84K sh
Reported value held$51.50M
Portfolio Weight2.53%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How SMITH CHAS P & ASSOCIATES PA CPAS's MRK position evolved

SMITH CHAS P & ASSOCIATES PA CPAS first disclosed a stake in MRK in Q3 2023 at 329,322 shares (US$33.9M). The position peaked in Q3 2026 at 352,837 shares, worth US$51.5M. Across 13 filings, SMITH CHAS P & ASSOCIATES PA CPAS increased the stake 4 time(s), trimmed it 5 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 352,837 shares valued at US$51.5M — a reduction of -6,761 shares quarter over quarter.. Notable position changes include a 36% trim in Q3 2025 (shares rose 26% over the following quarter), a 62% increase in Q4 2025 (shares rose 15% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 329.32K $33.90M New
Q4 2023 333.74K $36.38M Add
Q1 2024 335.12K $44.22M Hold
Q2 2024 335.26K $41.51M Hold
Q3 2024 331.64K $37.66M Reduce
Q4 2024 329.99K $32.83M Hold
Q1 2025 341.24K $30.63M Add
Q2 2025 355.25K $28.12M Add
Q3 2025 228.53K $19.18M Reduce
Q4 2025 370.94K $39.04M Add
Q1 2026 367.52K $44.21M Reduce
Q2 2026 359.60K $46.21M Reduce
Q3 2026 352.84K $51.50M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MRK and 13F data

MRK (MERCK & CO) is a Health Care company. 30 other funds we track also report a position in MRK — the largest reported positions include BlackRock Inc (US$29.17B), Vanguard Group (US$26.77B), VANGUARD CAPITAL MANAGEMENT LLC (US$23.47B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MRK

All MRK fund holders →

FAQ

How long has SMITH CHAS P & ASSOCIATES PA CPAS held MRK?

SMITH CHAS P & ASSOCIATES PA CPAS has disclosed MRK holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is SMITH CHAS P & ASSOCIATES PA CPAS's current position in MRK?

As of Q3 2026, SMITH CHAS P & ASSOCIATES PA CPAS holds 352.84K shares of MRK (MERCK & CO), valued at $51.50M, representing 2.53% of its reported portfolio and ranking #14.

Has SMITH CHAS P & ASSOCIATES PA CPAS been buying or selling MRK?

In the latest 13F filing (Q3 2026), SMITH CHAS P & ASSOCIATES PA CPAS reduced its position in MRK. The position peaked in Q3 2026 at 352.84K shares.

Which other funds hold MRK?

Other major institutional holders of MRK include BlackRock Inc, Vanguard Group, VANGUARD CAPITAL MANAGEMENT LLC, among 30 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.